Literature DB >> 3943738

Retinal detachment following intraocular lens implantation.

C P Wilkinson.   

Abstract

This report concerns a consecutive series of 154 pseudophakic eyes in which primary scleral buckling procedures were performed for rhegmatogenous retinal detachments. Most cases involved eyes in which extracapsular surgery had been combined with iridocapsular implants or posterior chamber lenses or in which iris-fixation intraocular lenses were placed following intracapsular surgery. The characteristics of the detachments were similar, although there was a trend towards an increased incidence of significant preoperative proliferative vitreoretinopathy in the intracapsular cases. Anatomical success rates were over 90% in all groups. There was a trend for lower visual acuities following successful surgery in the eyes in which intracapsular surgery had been performed than in those following extracapsular procedures.

Entities:  

Mesh:

Year:  1986        PMID: 3943738     DOI: 10.1007/bf02144138

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  6 in total

1.  Pseudophakic retinal detachments.

Authors:  C P Wilkinson
Journal:  Retina       Date:  1985 Winter-Spring       Impact factor: 4.256

2.  Pseudophakic retinal detachment.

Authors:  W S Hagler
Journal:  Trans Am Ophthalmol Soc       Date:  1982

3.  The classification of retinal detachment with proliferative vitreoretinopathy.

Authors: 
Journal:  Ophthalmology       Date:  1983-02       Impact factor: 12.079

4.  Retinal detachment after phacoemulsification.

Authors:  C P Wilkinson
Journal:  Am J Ophthalmol       Date:  1979-05       Impact factor: 5.258

5.  Retinal detachments following intraocular lens implantation.

Authors:  C P Wilkinson
Journal:  Ophthalmology       Date:  1981-05       Impact factor: 12.079

6.  Retinal detachment in myopic eyes after intracapsular and extracapsular cataract extraction.

Authors:  N S Jaffe; H M Clayman; M S Jaffe
Journal:  Am J Ophthalmol       Date:  1984-01       Impact factor: 5.258

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.